Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)
- First Posted Date
- 2020-07-02
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Mesoblast International Sàrl
- Registration Number
- NCT04456439
Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection
- First Posted Date
- 2020-04-29
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Mesoblast International Sàrl
- Registration Number
- NCT04366830
- Locations
- 🇺🇸
Mount Sinai Hospital, New York, New York, United States
Follow-up Study of Chondrogen® Delivered by Intra-Articular Injection Following Meniscectomy
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-06-20
- Last Posted Date
- 2022-01-11
- Lead Sponsor
- Mesoblast International Sàrl
- Target Recruit Count
- 55
- Registration Number
- NCT00702741
- Locations
- 🇺🇸
TRIA Orthopaedic Center, Bloomington, Minnesota, United States
🇺🇸University of Southern California Keck School of Medicine, Los Angeles, California, United States
🇺🇸Unlimited Research, San Antonio, Texas, United States
A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-23
- Last Posted Date
- 2021-12-27
- Lead Sponsor
- Mesoblast International Sàrl
- Target Recruit Count
- 60
- Registration Number
- NCT00225095
- Locations
- 🇺🇸
Orthopedic Center of Vero Beach, Vero Beach, Florida, United States
🇺🇸Ortholndy, Indianapolis, Indiana, United States
🇺🇸Greater Chesapeake Associates, Baltimore, Maryland, United States
OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies
Phase 2
Withdrawn
- Conditions
- First Posted Date
- 2004-04-08
- Last Posted Date
- 2014-12-04
- Lead Sponsor
- Mesoblast International Sàrl
- Registration Number
- NCT00081055
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
© Copyright 2024. All Rights Reserved by MedPath